Company

International Stem Cell CORP (ISCO)

Standardized SEC financial data for International Stem Cell CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001355790 · OTC · Pharmaceutical Preparations.

Gross margin

55.7%

Operating margin

-2.9%

Net margin

-4.6%

Revenue growth (YoY)

0.2%

Return on equity

10.3%

Free cash flow

-$35K

Current ratio

0.74×

EPS (diluted)

$-0.05

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$7.1M	$7.2M	$8.2M	$7.8M	$9.1M	$9.1M
Cost of revenue	$2.8M	$2.9M	$3.3M	$3.2M	$3.8M	$4.0M
Gross profit	$4.3M	$4.2M	$4.9M	$4.6M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$689K	$171K	$742K	$1.6M	$1.2M	$993K
Inventory	$1.9M	$2.1M	$2.3M	$2.3M	$2.1M	$2.5M
Total current assets	$2.2M	$2.3M	$3.0M	$3.5M	$3.6M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$341K	-$1.3M	$332K	$929K	$13K	$8K
Capital expenditures	$28K	$23K	$1K	$80K	$166K	$43K
Free cash flow	-$369K	-$1.3M	$331K	$849K	-$153K

Get ISCO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ISCO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ISCO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ISCO filings on SEC EDGAR →